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http://dx.doi.org/10.1016/j.pedneo.2Background: Pneumonia caused by Streptococcus pneumoniae is the leading cause of death
among children in Ethiopia. S. pneumoniae nasopharyngeal carriage can result in endogenous
infections and bacterial spread in the community. S. pneumoniae drug resistance is rapidly
increasing worldwide. The aim of the study was to assess the nasopharyngeal carriage and anti-
microbial susceptibility pattern of S. pneumoniae among pediatric outpatients.
Methods: A cross-sectional study was conducted on children aged 10 years from February to
May of 2012. Data on potential risk factors were gathered using an interview-based question-
naire. Nasopharyngeal specimens were collected with a sterile plastic cotton tip swab. Bacte-
ria were characterized by colony appearance, Gram staining, and optochin susceptibility and
bile solubility tests. An antimicrobial susceptibility test was performed using the disk diffusion
method. A logistic regression analysis was used to examine the possible risk factors. All tests
with p value less than 0.05 were considered statistically significant.
Results: Of the 234 children screened, 41.03% carried S. pneumoniae. Age-related downward
trend for S. pneumoniae carriages (50.9% in <3-year-olds, 40.7% in 3- to 5-year-olds, 40.0% in
5- to <8-year-olds, and 33.3% in 8- to 10-year-olds) were observed. Children living withof Medical Microbiology, University of Gondar, Gondar, Ethiopia.
om, abateasseafa@yahoo.com (A. Assefa).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
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316 A. Assefa et alsiblings < 5 years old (pZ 0.003) and in a house having one room (pZ 0.004) were associated
with higher S. pneumoniae carriage. S. pneumoniae showed 33.2% resistance to erythromycin
and tetracycline, 29.2% to cotrimoxazole, 14.6% to chloramphenicol and ciprofloxacin, and
10.4% to penicillin.
Conclusion: The S. pneumoniae carriage rate was higher among younger children. High antimi-
crobial resistance of S. pneumoniae against erythromycin, tetracycline, and cotrimoxazole was
observed. Being in the young age group and living with younger children are risk factors for
pneumococcal carriage.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Streptococcus pneumoniae is a component of normal
nasopharyngeal flora in children. Nasopharyngeal coloni-
zation begins shortly after birth. Although nasopharyngeal
pneumococcal carriage is usually asymptomatic, it may
subsequently serve as the focus for infections in children,
the elderly, the immune-compromised, and individuals with
chronic disease. S. pneumoniae is the etiology of many
diseases including pneumonia, bacteremia, meningitis,
otitis media, and sinusitis.1
One million children die annually from pneumococcal
diseases.1 Pneumonia constitutes a major proportion of the
global burden of childhood disease, being responsible for
about 20% of childhood deaths, the majority of which occur
in developing countries.2 Childhood community-acquired
pneumonia accounts for 30% to 40% of hospital admissions
with associated case fatality rates of between 15% and
28%.3 Pneumonia kills more children than any other illness
and is responsible for 4300 childhood deaths every day, or
one in every 20 seconds globally.4 In Ethiopia, pneumonia is
the leading cause of death among children, and each year
more than 100,000 children die before their 5th birthday
due to pneumonia, which accounts for 28% of under-5
mortality.5 S. pneumoniae is the leading cause of bacte-
rial pneumonia, being identified in 30e50% of cases,6 and it
is therefore considered the biggest infectious killer of
children under 5 years old in Ethiopia.4
In Africa, pneumococcal meningitis case fatality rates
reach 45%. Even with appropriate treatment, pneumo-
coccal meningitis kills approximately one-third of affected
African children.7 In sub-Saharan Africa, S. pneumoniae was
found to account for about 25% to >30% of meningitis cases
in children under 5 years, with a case fatality rate of
>50%.8
For many years, penicillin and chloramphenicol have
been the mainstay of treatment for pneumococcal disease
in developing countries, as they are both inexpensive and
effective. Unfortunately, the rapid increase in resistance to
penicillin and other antimicrobial agents worldwide has
made the choice of antimicrobial drugs for S. pneumoniae
infections more difficult and costly.9,10 Moreover, naso-
pharyngeal colonization by antibiotic-resistant S. pneumo-
niae has been increasing steadily.10e16
Several clinical and demographic characteristics have
been positively associated with an increase in S. pneumo-
niae colonization, such as young age, crowding, day-careattendance, family size, number of siblings, poverty,
smoking, and recent antibiotic use.17,18 Although nasopha-
ryngeal isolates are not useful in predicting the causative
agent of invasive disease in individuals, they reflect the
epidemiological aspects of S. pneumoniae disease in the
community.19 The bacteria carried in the nasopharynx of
healthy children reflect the infection-causing strains
currently circulating in the community.20 Studies conducted
over the past decades have gradually revealed the
connection between S. pneumoniae carriage, and mucosal
and invasive infections caused by the organism.17,21
It was also identified that asymptomatic carriage was a
prerequisite for developing invasive and noninvasive S.
pneumoniae diseases,17 and carriers serve as sources of S.
pneumoniae transmission to others in the community and in
the hospital.22 Furthermore, S. pneumoniae carriage strains
have been used as indicators for antimicrobial resistance
strains and are helpful in designing appropriate empirical
antimicrobial therapies.23,24 Therefore, studies of the
prevalence of S. pneumoniae, their resistance patterns,
and possible risk factors can provide useful indications for
more rational therapeutic and preventive strategies. In
African countries, children are suffering from extremely
high burdens of S. pneumoniae diseases, and therapy for
pneumococcal disease remains empiric because of the lack
of rapid, sensitive, and specific diagnostic tests. In many
African countries and particularly in Ethiopia, there are no
epidemiologic data on S. pneumoniae. Therefore, the aim
of this study was to determine nasopharyngeal carriage
rate, antimicrobial susceptibility pattern, and possible risk
factors of S. pneumoniae among pediatric outpatients
attending Gondar University Hospital, Ethiopia.2. Methods and Materials2.1. Study design and participants
This study was conducted on children who were attending
Gondar University Hospital pediatrics outpatient depart-
ment from February 15 to May 15, 2012. Based on figures
from the Central Statistical Agency in 2008, Gondar has an
estimated total population of 231,977. Gondar University
Hospital is a referral hospital with more than 400 beds for
North West Ethiopia serving a population of about 5 million.
All children aged 10 years and below and who were seen for
either well-child care visits or sick care visits were eligible
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participants were selected using a systematic random
sampling method. Based on the available data, the total
number of children aged 10 years and below who visited the
pediatrics outpatient department for any reason in the 3-
month period reached 600 (280 respiratory cases and 320
nonrespiratory cases). Every third child seen in this 3-
month period was recruited for the study, giving a total
study population of 234 (110 respiratory and 320 non-
respiratory cases).
2.2. Collection of demographic and clinical
characteristics
The study was reviewed and approved by the institutional
review board of the University of Gondar. Written informed
consent was obtained from each participant’s parent(s) or
legal guardian. Individual records were coded and accessed
only by research staff. After written informed consent was
obtained, three trained interns from the pediatrics
department conducted questionnaire-based interviews
with the parents or guardians of the children to collect the
necessary sociodemographic information. Sociodemo-
graphic information included in this study comprised age,
sex, family size, siblings < 5 years, siblings  5 years,
number of rooms in the house, and habits of sleeping with
parents. In addition, the clinical presentation of illness
(upper and lower respiratory tract infection) was collected
after clinical diagnosis by the same questionnaire. Each
child suspected of having tuberculosis (TB) was sent to the
radiology department for chest X-ray and with the same
radiologist performing the procedure.
2.3. Nasopharyngeal specimen collection and
processing
Nasopharyngeal specimens were obtained by the same
trained interns according to the Centers for Disease Control
manual.25 One nasopharyngeal specimen per child was ob-
tained with a sterile synthetic cotton swab on flexible
aluminum wire (Fisher Scientific, Pittsburgh, PA, USA). After
sampling, swabswere placed immediately into Amiesmedium
(Oxoid, Basingstoke, Hamsphire, England) and transported to
the microbiology laboratory. Within 4 hours of collection, the
specimens were inoculated onto blood agar (HiMedia, Mum-
bai, India) supplemented with 5 mg/mL gentamycin plates
(Nathan Pirumal, Bombay, India) by rolling the swab over a
small area of the plate and streaking the sample using a sterile
loop. The inoculated media were then incubated under 5%
CO2-enriched atmosphere at 37
C for 24e48 hours.
2.4. Identification of bacterial isolates
All isolates were identified based on the method outlined
by the Centers for Disease Control.25 Gram-positive cocci a-
hemolytic colonies on blood agar supplemented with 5 mg/
mL gentamycin plates were picked up with a wire loop and
subcultured onto blood agar plates. An optochin disk with a
diameter of 6 mm (5 mg ethylhydrocupreine) was placed
aseptically on the streak of inoculum. The plate was incu-
bated in a 5% CO2 atmosphere at 37
C for 18e24 hours.Isolates with a zone of inhibition  14 mm in diameter were
considered susceptible to optochin. Strains with zones of
inhibition ranging from 9 mm to 13 mm were tested for bile
solubility for confirmation using 2% sodium deoxycholate
(bile salt) (Oxoid, Basingstoke, Hamsphire, England).
2.5. Antimicrobial susceptibility testing
Antimicrobial susceptibility test to erythromycin (15 mg),
chloramphenicol (30 mg), ceftriaxone (10 mg), cotrimoxazole
(25 mg), tetracycline (30 mg), vancomycin (30 mg), cipro-
floxacin (5 mg), and oxacillin (1 mg) (Oxoid, Basingstoke,
Hamsphire, England) were carried out using a disk diffusion
method (modified KirbyeBauer) on Muller Hinton agar
(Oxoid, Basingstoke, Hamsphire, England) supplemented
with 5% sheep’s blood. Based on nonmeningeal isolates of
S. pneumoniae interpretation, penicillin susceptibility
testing was performed using oxacillin (1 mg) disks.26,27 To
standardize the inoculum density for susceptibility tests, a
0.5 McFarland standard (Thermo Oxoid Remel) was used.
Within 15 minutes after adjusting the turbidity of the inoc-
ulum suspension, a sterile cotton swab was dipped into the
adjusted suspension. The dried surface plates were inocu-
lated by streaking the swab over the entire sterile agar
surface. The antimicrobial disks were placed on the lawn of
bacterial isolates using sterile forceps. Inoculated media
were incubated in a 5% CO2 atmosphere for 18e24 hours at
37C. The results were interpreted by comparing the results
to the standard zone sizes of the Clinical and Laboratory
Standard Institute. S. pneumoniae ATCC 49619 was used as
the quality control strain for each run as recommended by
the Clinical and Laboratory Standard Institute.27
2.6. Statistical analysis
The data were analyzed by SPSS package software version
SPSS 16.0.2 (SPSS Inc., Chicago. IL, USA). A descriptive
analysis was used to determine the demographic charac-
teristics and the prevalence of each isolate. The association
between the characteristics of the children and the car-
riage of S. pneumoniae was first analyzed by a series of
bivariate analyses. Then, to control simultaneously for the
possible confounding effects of the different variables, the
risk of being an S. pneumoniae carrier was estimated by
multivariate analysis with stepwise variable selection. In
both analyses, the association was expressed in odds ratios
(ORs) and 95% confidence intervals (CI). All tests of multi-
variate analysis with p value <0.05 were considered sta-
tistically significant.
3. Results
3.1. Demographic and clinical characteristics
A total of 234 children were enrolled in the study, of whom
121 (51.7%) were female. The mean age of the children was
5.2 years with a standard deviation of 3.0 years. One hun-
dred and thirty-three (56.8%) lived in urban environments.
The majority of the children 148 (63.2%) were living within
a single room (house with only one room), and only 17
Table 1 Sociodemographic and clinical characteristics of
234 study participants recruited from pediatric outpatients
at University of Gondar Hospital, February 15 to May 15,
2012.
Characteristics of children (n Z 234) n %
Sex Male 113 48.3
Female 121 51.7
Residence Urban 133 56.8
Rural 101 43.2
Age (y) <3 57 24.4
3 to <5 54 23.4
5 to <8 60 25.6
8 to 10 63 26.9
Family size <5 90 38.5
5þ 144 61.5
Siblings < 5 y Yes 102 43.6
No 132 56.4
Siblings  5 y Yes 156 66.7
No 78 33.3
Sleeping with parents Yes 217 92.7
No 17 7.3
Number of rooms 1 148 63.2
2þ 86 36.8
Recent use of antibiotics Yes 87 37.2
No 147 62.8
URTI No 195 83.3
TP 16 6.8
Sinusitis 23 9.8
LRTI No 175 74.8
Pn 27 11.5
TB 32 13.7
Otitis media Yes 12 5.1
No 222 94.9
LRTI Z lower respiratory tract infection; Pn Z pneumonia;
TB Z tuberculosis; TP Z tonsilopharyngitis; URTI Z upper
respiratory tract infection.
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(37.2%) children had received antibiotics within the past 2
weeks of enrolment. During enrolment, 98 (41.9%) of the
children were clinically diagnosed as having a respiratory
infection (Table 1).
3.2. Nasopharyngeal carriage of S. pneumoniae
Of the 234 children screened, 96 (41.03%) were carriers of S.
pneumoniae. The highest S. pneumoniae carriage rate was
observed in children aged< 3 years (29 children, 50.9%). The
proportion of S. pneumoniae carriage was 49 (43.4%) in
males versus 47 (38.8%) in females. In children living with
<5-year-old siblings, the overall S. pneumoniae carriage rate
was 50 (49.0%). Of the 156 children living with 5-year-old
siblings, 64 (41.0%) had S. pneumoniae (Table 2).
3.3. Risk factor analysis for S. pneumoniae
nasopharyngeal carriage
The highest S. pneumoniae carriage rate (50.9%) was
observed in children aged less than 3 years old. Being withinthe younger age groups (<3 years) was significantly associ-
ated with S. pneumoniae carriage (adjusted ORZ 3.4; 95%
CI, 1.4e8.73; p Z 0.007). In addition, S. pneumoniae car-
riage was significantly higher in children living with
siblings < 5 years old (adjusted OR Z 2.84; 95% CI,
1.40e5.76; p Z 0.004). Moreover, there was a significant
association between carriage by S. pneumoniae and number
of rooms in the house (OR Z 2.96; 95% CI, 1.46e5.99;
p Z 0.003) and being pneumonia patients (adjusted
ORZ 3.55; 95% CI, 1.37e9.20; pZ 0.009). However, there
was no significant association between, sex, residence, and
family size, children living with siblings  5 years old,
sleeping with parents or use of antibiotics within the previ-
ous 2 weeks, and carriage rate by S. pneumoniae (Table 2).
3.4. Antimicrobial susceptibility patterns of
bacterial isolates
The antibiotic susceptibility pattern of all isolates of S.
pneumoniae is shown in Table 3. Only two S. pneumoniae
were susceptible to all of the antibiotics tested, 75 (78.1%)
were resistant to one antimicrobial agent, eight (8.3%) were
resistant to two, and 11 (11.5%) to more than two. Ten
(10.4%) penicillin-resistant S. pneumoniae were isolated.
Thirty-two (33.3%) S. pneumoniae isolates were resistant to
erythromycin and tetracycline, and 22 (22.9%)were resistant
and six (6.3%) were intermediately resistant to cotrimox-
azole. However, all isolates of S. pneumoniae were suscep-
tible to ceftriaxone and vancomycin. Nineteen (19.8%) of the
S. pneumoniae isolates were resistant to two or more anti-
microbial agents. Six penicillin-resistant S. pneumoniae
were also resistant to two or more antibiotics tested.
4. Discussion
In this study, a high carriage rate (41.03%) of S. pneumoniae
was observed. Although the nasopharyngeal carriage rate of
S. pneumoniae among children varies widely throughout
the world, the current result was in harmony with various
studies.23,28e30 This may, therefore, suggest that large
numbers of pneumococcal carriers are at high risk of devel-
oping invasive and noninvasive pneumococcal diseases and
that family members are at risk of acquiring the pathogens.
The higher isolation rates of S. pneumoniae among children
place at risk not only their families but also their peers with
whom they interact in the community. The high prevalence of
S. pneumoniae could be because many children may be
immunocompromised as a result of the diseases that promp-
ted them to visit the hospital. Comparatively lower S. pneu-
moniae carriage was reported in Taiwan (14%),31 Turkey
(13.9%),14 and Finland (5.4%).32 However, higher carriage of
S. pneumoniae (87%) was reported in Mozambique among
younger children (1 month to <5 years)33 and in Belgium
69%.23 Seasonal variation andmethodological differencesmay
explain the differences in reported pneumococci carriage.
In our results, S. pneumoniae showed an age-related
downward trend. Children belonging to the age group of
<3 years were the most colonized (29: 50.9%), followed by
those 3e5 years of age (22: 40.7%). Children between 8
years and 10 years were the least vulnerable to pneumo-
coccal nasopharyngeal carriage (21: 33.3%). These findings
Table 2 Bivariate and multivariate analyses of risk factors for Streptococcus pneumoniae carriage in 234 study participants
recruited from pediatric outpatients at the University of Gondar Hospital.
Variable n (%) S. pneumoniae (n Z 96) OR with 95% CI
No Yes Crude OR (95% CI) Adjusted OR (95% CI) p
n (%) n (%)
Sex Female 121 (51.7) 74 (61.2) 47 (38.8) 0.830 (0.49e1.4) 0.92 (0.51e1.7) 0.783
Male 113 (48.3) 64 (56.6) 49 (43.4) 1 1
Age (y) <3 57 (24.4) 28 (49.1) 29 (50.9) 2.07 (0.99e4.3) 3.5 (1.4e8.7) 0.007
3 to <5 54 (23.4) 32 (59.3) 22 (40.7) 1.38 (0.65e2.9) 1.6 (0.68e3.9) 0.275
5 to <8 60 (25.6) 36 (60.0) 24 (40.0) 1.33 (0.64e2.8) 1.8 (0.75e4.4) 0.183
8-10 63 (26.9) 48 (76.2) 21 (33.3) 1 1
Residence Rural 133 (56.8) 78 (58.6) 55 (41.4) 1.03 (0.61e1.7) 0.69 (0.33e1.4) 0.324
Urban 101 (43.2) 60 (59.4) 41 (40.6) 1 1
Family size <5 90 (38.5) 54 (60.0) 36 (40.0) 1.07 (0.63e1.8) 1.38 (0.69e2.74) 0.358
5þ 144 (61.5) 84 (58.3) 60 (41.7) 1 1
Siblings < 5 y Yes 102 (43.6) 52 (51.0) 50 (49.0) 1.79 (1.06e3.05) 2.84 (1.40e5.76) 0.004
No 132 (56.4) 86 (65.2) 46 (34.8) 1 1
Siblings  5 y Yes 156 (66.7) 92 (59.0) 64 (41.0) 1.00 (0.58e1.7) 0.70 (0.33e1.51) 0.362
No 78 (33.3) 46 (59.0) 32 (41.0) 1 1
Sleeping with
parents
Yes 156 (66.7) 92 (59.0) 64 (41.0) 1.73 (0.59e5.09) 0.72 (0.22e2.42) 0.600
No 78 (33.3) 46 (59.0) 32 (41.0) 1 1
Number of
rooms in house
1 148 (63.2) 126 (58.1)) 91 (41.9) 2.25 (1.28e3.96) 2.96 (1.46e5.99) 0.003
2þ 86 (36.8) 12 (70.6) 5 (29.4)) 1 1
Recent
antibiotic use
Yes 87 (37.2) 77 (52.0) 71 (48.0) 0.879 (0.51e1.51) 0.89 (0.48e1.64) 0.701
No 147 (62.8) 61 (70.9) 25 (29.1) 1 1
Otitis media Yes 12 (5.1) 5 (41.7) 7 (58.3) 2.1 (0.65e6.80) 2.20 (0.58e8.31) 0.246
No 222 (94.9) 133 (59.9) 89 (40.1) 1 1
URTI TP 16 (6.8) 10 (62.5) 6 (37.5) 1.61 (0.58e4.49) 2.84 (0.82e9.86) 0.101
Sinusitis 22 (9.4) 12 (54.5) 10 (45.5) 1.48 (0.62e3.54) 1.92 (0.71e5.15) 0.198
No 196 (83.8) 108 (58.7) 76 (41.3) 1 1
LRTI Pn 27 (11.5) 15 (55.6) 12 (44.4) 1.85 (0.81e4.24) 3.55 (1.37e9.20) 0.009
TB 32 (13.8) 23 (71.9) 9 (28.1) 1.24 (0.58e2.65) 1.60 (0.64e4.03) 0.316
No 175 (74.8) 100 (57.1) 75 (42.9) 1 1
CI Z confidence interval; LRTI Z lower respiratory tract infection; OR Z odds ratio; Pn Z pneumonia; TB Z tuberculosis;
TP Z tonsilopharyngitis; URTI Z upper respiratory tract infection.
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Israel, and Kenya.28,29,34 The decline in S. pneumoniae
carriage rate associated with increasing age may reflect the
gradual acquisition of mucosal immunity and reduction ofTable 3 Antimicrobial susceptibility patterns of Strepto-
coccus pneumoniae, isolated from 234 study participants
recruited from the pediatric outpatients at the University of
Gondar Hospital.
Antimicrobials S. pneumoniae (n Z 96)
Resistant Intermediate Susceptible
n (%) n (%) n (%)
Cotrimoxazole 22 (22.9) 6 (6.3) 66 (68.8)
Chloramphenicol 14 (14.6) 0 (0) 82 (85.4)
Erythromycin 32 (33.2) 0 (00) 64 (66.7)
Tetracycline 32 (33.2) 0 (00) 64 (66.7)
Ceftriaxone 0 (0) 0 (0) 96 (100)
Ciprofloxacin 2 (2.1) 12 (12.5) 82 (85.4)
Vancomycin 0 (0) 0 (0) 96 (100)
Penicillin 10 (10.4) 0 (0) 86 (89.6)exposure. The findings may highlight that younger age
groups have a higher risk of acquiring S. pneumoniae
compared with older age groups.
Various demographic characteristics have been described
to be associated with an increase in S. pneumoniae carriage
including family size, recent antibiotic use, and habit of
sleeping with parents.17 In our study, none of these factors
were found to be associated with nasopharyngeal S. pneu-
moniae carriage. Unidentified environmental or host factors
(underlying diseases, immunosuppression) may be the
prime determinants of the carriage distribution in the
study participants. However, in logistic regression analysis,
S. pneumoniae carriage rates were significantly associated
with younger age (<3 years old). The environmental factor,
children living with <5-year-old siblings, showed signifi-
cantly higher S. pneumoniae carriage compared with chil-
dren who do not have any younger siblings. These findings
were similar to reports from Israel, Mozambique, and
Gambia.15,29,33 This is of great relevance because exposure
to other children during childhood, especially to younger
siblings, has been clearly associated with an increased
risk for invasive and noninvasive pneumococcal disease.
Moreover, we observed significantly higher S. pneumoniae
320 A. Assefa et alnasopharyngeal carriages rates among children who lived
with their family in a house with only one room and other
children. This result is consistent with the report from
Mozambique.33 These findings may highlight high S. pneu-
moniae transmission in overcrowded areas.
The results of the antimicrobial susceptibility study
revealed higher S. pneumoniae resistance: 32 (33.3%) to
erythromycin and tetracycline; 28 (29.1%) to cotrimoxazole;
and 14 (14.6%) to ciprofloxacin. Nineteen (19.8%) isolated
S. pneumoniae were multidrug resistant. This observation of
S. pneumoniae resistance to erythromycin, tetracycline, and
cotrimoxazole is consistent with previous reports in
Venezuela and Gambia.10,15 By contrast, 10 (10.4%) S. pneu-
moniae were penicillin-resistant. Comparable penicillin-
resistant S. pneumoniae results were reported in various
studies: 14.3% in Gambia15 and 7% in Brazil and Turkey.11,12
However, higher proportions of penicillin-resistant pneumo-
cocci were found in Japan (60.6%),30 Mexico (34%),35 and
Mozambique (58.9%).33 Pneumococci resistance rates to
penicillin vary according to geographic region and different
population subgroups. Geographical variations in the anti-
microbial susceptibility of S. pneumoniae can beexplained by
the general consumption of antimicrobial agents. The most
effective antimicrobial agents for the S. pneumoniae isolates
were ceftriaxone and vancomycin, to which these isolates
were 100% susceptible. This pneumococcal sensitivity to
vancomycin was consistent with the report in Venezuela.10
Ceftriaxone and vancomycin, however, are relatively more
costly. Together with biological factors, these factors could
be responsible for the low rate of resistance recorded for
ceftriaxone and vancomycin drugs. Although cotrimoxazole,
erythromycin, and tetracycline are cheap and readily avail-
able to the local population, they showed higher resistance.
Therefore, the uncontrolled availability of some antimicro-
bial agents, leading to frequent use and misuse, exerts
greater selection pressure for the resistant strains and
thereby makes these agents almost ineffective.
5. Conclusions
S. pneumoniae nasopharyngeal carriage was higher among
children under 3 years of age. These high numbers of carrier
children could serve as reservoirs for the transmission of S.
pneumoniae to younger children in the community, which
could lead to serious pneumococcal diseases and associated
health consequences. Therefore, there is an urgent need to
expand the pneumococcal conjugate vaccination in the
community. Being in the young age group, living with
younger children, and living in a house having a single room
are risk factors for S. pneumoniae carriage. Higher S.
pneumoniae drug resistance was observed for erythromycin,
tetracycline, and cotrimoxazole. Further determination of
the association of nasopharyngeal carriage of resistant
strains with development of invasive resistant strain infec-
tion is important for establishing rational treatment for
presumptive S. pneumoniae infections.
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